{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:44:35Z","timestamp":1790685875502,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hyperglycemia (HG) stimulates the production of reactive oxygen species in the heart through activation of NADPH oxidase 2 (NOX2). This production is independent of glucose metabolism but requires sodium\/glucose cotransporters (SGLT). Seven SGLT isoforms (SGLT1 to 6 and sodium-myoinositol cotransporter-1, SMIT1) are known, although their expression and function in the heart remain elusive. We investigated these 7 isoforms and found that only SGLT1 and SMIT1 were expressed in mouse, rat and human hearts. In cardiomyocytes, galactose (transported through SGLT1) did not activate NOX2. Accordingly, SGLT1 deficiency did not prevent HG-induced NOX2 activation, ruling it out in the cellular response to HG. In contrast, myo-inositol (transported through SMIT1) reproduced the toxic effects of HG. SMIT1 overexpression exacerbated glucotoxicity and sensitized cardiomyocytes to HG, whereas its deletion prevented HG-induced NOX2 activation. In conclusion, our results show that heart SMIT1 senses HG and triggers NOX2 activation. This could participate in the redox signaling in hyperglycemic heart and contribute to the pathophysiology of diabetic cardiomyopathy.<\/jats:p>","DOI":"10.1038\/srep41166","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T05:38:16Z","timestamp":1485495496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart"],"prefix":"10.1038","volume":"7","author":[{"given":"Anne","family":"Van Steenbergen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Balteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Ginion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fert\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Battault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe de Meester de","family":"Ravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Balligand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos-Panagiotis","family":"Daskalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Despa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda","family":"Despa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vanoverschelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Horman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Koepsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"BFsrep41166_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.CIR.99.4.461","volume":"99","author":"M Laakso","year":"1999","unstructured":"Laakso, M. Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study. Circulation 99, 461\u2013462 (1999).","journal-title":"Circulation"},{"key":"BFsrep41166_CR2","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","volume":"21","author":"H King","year":"1998","unstructured":"King, H., Aubert, R. E. & Herman, W. H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414\u20131431 (1998).","journal-title":"Diabetes Care"},{"key":"BFsrep41166_CR3","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/hs1001.096194","volume":"32","author":"SE Capes","year":"2001","unstructured":"Capes, S. E., Hunt, D., Malmberg, K., Pathak, P. & Gerstein, H. C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32, 2426\u20132432 (2001).","journal-title":"Stroke"},{"key":"BFsrep41166_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1161\/CIRCULATIONAHA.107.740498","volume":"117","author":"M Kosiborod","year":"2008","unstructured":"Kosiborod, M. et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117, 1018\u20131027 (2008).","journal-title":"Circulation"},{"key":"BFsrep41166_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/CS20090322","volume":"118","author":"IB Squire","year":"2010","unstructured":"Squire, I. B. et al. Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: results from 4702 index cases in routine practice. Clin Sci (Lond) 118, 527\u2013535 (2010).","journal-title":"Clin Sci (Lond)"},{"key":"BFsrep41166_CR6","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1210\/jc.2005-1904","volume":"91","author":"D Dyntar","year":"2006","unstructured":"Dyntar, D. et al. High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation. J Clin Endocrinol Metab 91, 1961\u20131967 (2006).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep41166_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa, T. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787\u2013790 (2000).","journal-title":"Nature"},{"key":"BFsrep41166_CR8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","volume":"51","author":"L Cai","year":"2002","unstructured":"Cai, L. et al. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51, 1938\u20131948 (2002).","journal-title":"Diabetes"},{"key":"BFsrep41166_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.yjmcc.2004.07.008","volume":"37","author":"F Fiordaliso","year":"2004","unstructured":"Fiordaliso, F. et al. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37, 959\u2013968 (2004).","journal-title":"J Mol Cell Cardiol"},{"key":"BFsrep41166_CR10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ Res 107, 1058\u20131070 (2010).","journal-title":"Circ Res"},{"key":"BFsrep41166_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/cvr\/cvr230","volume":"92","author":"M Balteau","year":"2011","unstructured":"Balteau, M. et al. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovascular research 92, 237\u2013246 (2011).","journal-title":"Cardiovascular research"},{"key":"BFsrep41166_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jdiacomp.2013.04.008","volume":"27","author":"J Rosenstock","year":"2013","unstructured":"Rosenstock, J. et al. One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target. J Diabetes Complications 27, 492\u2013500 (2013).","journal-title":"J Diabetes Complications"},{"key":"BFsrep41166_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00424-003-1202-0","volume":"447","author":"EM Wright","year":"2004","unstructured":"Wright, E. M. & Turk, E. The sodium\/glucose cotransport family SLC5. Pflugers Arch 447, 510\u2013518 (2004).","journal-title":"Pflugers Arch"},{"key":"BFsrep41166_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2337\/db11-1029","volume":"61","author":"V Gorboulev","year":"2012","unstructured":"Gorboulev, V. et al. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61, 187\u2013196 (2012).","journal-title":"Diabetes"},{"key":"BFsrep41166_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mam.2012.11.002","volume":"34","author":"EM Wright","year":"2013","unstructured":"Wright, E. M. Glucose transport families SLC5 and SLC50. Mol Aspects Med 34, 183\u2013196 (2013).","journal-title":"Mol Aspects Med"},{"key":"BFsrep41166_CR16","first-page":"F459","volume":"263","author":"RG Wells","year":"1992","unstructured":"Wells, R. G. et al. Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Physiol 263, F459\u2013465 (1992).","journal-title":"Am J Physiol"},{"key":"BFsrep41166_CR17","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1073\/pnas.1733027100","volume":"100","author":"A Diez-Sampedro","year":"2003","unstructured":"Diez-Sampedro, A. et al. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA 100, 11753\u201311758 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep41166_CR18","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1101\/gr.146600","volume":"10","author":"MT Pletcher","year":"2000","unstructured":"Pletcher, M. T. et al. Chromosome evolution: the junction of mammalian chromosomes in the formation of mouse chromosome 10. Genome Res 10, 1463\u20131467 (2000).","journal-title":"Genome Res"},{"key":"BFsrep41166_CR19","doi-asserted-by":"publisher","first-page":"C1073","DOI":"10.1152\/ajpcell.00436.2011","volume":"302","author":"S Barcelona","year":"2012","unstructured":"Barcelona, S., Menegaz, D. & Diez-Sampedro, A. Mouse SGLT3a generates proton-activated currents but does not transport sugar. Am J Physiol Cell Physiol 302, C1073\u20131082 (2012).","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFsrep41166_CR20","doi-asserted-by":"publisher","first-page":"C58","DOI":"10.1152\/ajpcell.00030.2010","volume":"299","author":"O Aljure","year":"2010","unstructured":"Aljure, O. & Diez-Sampedro, A. Functional characterization of mouse sodium\/glucose transporter type 3b. Am J Physiol Cell Physiol 299, C58\u201365 (2010).","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFsrep41166_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.lfs.2004.10.016","volume":"76","author":"S Tazawa","year":"2005","unstructured":"Tazawa, S. et al. SLC5A9\/SGLT4, a new Na+ -dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci 76, 1039\u20131050 (2005).","journal-title":"Life Sci"},{"key":"BFsrep41166_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.febslet.2011.12.027","volume":"586","author":"R Grempler","year":"2012","unstructured":"Grempler, R. et al. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. FEBS Lett 586, 248\u2013253 (2012).","journal-title":"FEBS Lett"},{"key":"BFsrep41166_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0028-3908(99)00162-8","volume":"39","author":"B Lubrich","year":"2000","unstructured":"Lubrich, B., Spleiss, O. & Gebicke-Haerter, P. J. & van Calker, D. Differential expression, activity and regulation of the sodium\/myo-inositol cotransporter in astrocyte cultures from different regions of the rat brain. Neuropharmacology 39, 680\u2013690 (2000).","journal-title":"Neuropharmacology"},{"key":"BFsrep41166_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.bbamem.2007.01.007","volume":"1768","author":"K Lahjouji","year":"2007","unstructured":"Lahjouji, K. et al. Expression and functionality of the Na+\/myo-inositol cotransporter SMIT2 in rabbit kidney. Biochim Biophys Acta 1768, 1154\u20131159 (2007).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep41166_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0026-0495(90)90145-3","volume":"39","author":"M Haneda","year":"1990","unstructured":"Haneda, M. et al. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism 39, 40\u201345 (1990).","journal-title":"Metabolism"},{"key":"BFsrep41166_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jcb.10631","volume":"90","author":"L Zhou","year":"2003","unstructured":"Zhou, L. et al. Human cardiomyocytes express high level of Na+\/glucose cotransporter 1 (SGLT1). J Cell Biochem 90, 339\u2013346 (2003).","journal-title":"J Cell Biochem"},{"key":"BFsrep41166_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cvr\/cvp190","volume":"84","author":"SK Banerjee","year":"2009","unstructured":"Banerjee, S. K., McGaffin, K. R., Pastor-Soler, N. M. & Ahmad, F. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res 84, 111\u2013118 (2009).","journal-title":"Cardiovasc Res"},{"key":"BFsrep41166_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","volume":"1","author":"J Chen","year":"2010","unstructured":"Chen, J. et al. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther 1, 57\u201392 (2010).","journal-title":"Diabetes Ther"},{"key":"BFsrep41166_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2796.2006.01746.x","volume":"261","author":"EM Wright","year":"2007","unstructured":"Wright, E. M., Hirayama, B. A. & Loo, D. F. Active sugar transport in health and disease. J Intern Med 261, 32\u201343 (2007).","journal-title":"J Intern Med"},{"key":"BFsrep41166_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1152\/physrev.00055.2009","volume":"91","author":"EM Wright","year":"2011","unstructured":"Wright, E. M., Loo, D. D. & Hirayama, B. A. Biology of human sodium glucose transporters. Physiol Rev 91, 733\u2013794 (2011).","journal-title":"Physiol Rev"},{"key":"BFsrep41166_CR31","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.2337\/db06-0531","volume":"55","author":"D O\u2019Malley","year":"2006","unstructured":"O\u2019Malley, D., Reimann, F., Simpson, A. K. & Gribble, F. M. Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 55, 3381\u20133386 (2006).","journal-title":"Diabetes"},{"key":"BFsrep41166_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00232001081","volume":"176","author":"A Diez-Sampedro","year":"2000","unstructured":"Diez-Sampedro, A., Lostao, M. P., Wright, E. M. & Hirayama, B. A. Glycoside binding and translocation in Na(+)-dependent glucose cotransporters: comparison of SGLT1 and SGLT3. J Membr Biol 176, 111\u2013117 (2000).","journal-title":"J Membr Biol"},{"key":"BFsrep41166_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00234656","volume":"143","author":"K Hager","year":"1995","unstructured":"Hager, K. et al. Kinetics and specificity of the renal Na+\/myo-inositol cotransporter expressed in Xenopus oocytes. J Membr Biol 143, 103\u2013113 (1995).","journal-title":"J Membr Biol"},{"key":"BFsrep41166_CR34","doi-asserted-by":"publisher","first-page":"H1120","DOI":"10.1152\/ajpheart.00210.2014","volume":"307","author":"M Balteau","year":"2014","unstructured":"Balteau, M. et al. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. American journal of physiology. Heart and circulatory physiology 307, H1120\u20131133 (2014).","journal-title":"American journal of physiology. Heart and circulatory physiology"},{"key":"BFsrep41166_CR35","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman, B. et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 373, 2117\u20132128 (2015).","journal-title":"N Engl J Med"},{"key":"BFsrep41166_CR36","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00424-014-1619-7","volume":"467","author":"I Vrhovac","year":"2015","unstructured":"Vrhovac, I. et al. Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch 467, 1881\u20131898 (2015).","journal-title":"Pflugers Arch"},{"key":"BFsrep41166_CR37","doi-asserted-by":"crossref","unstructured":"Song, P., Onishi, A., Koepsell, H. & Vallon, V. Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. Expert Opin Ther Targets, 1\u201317 (2016).","DOI":"10.1517\/14728222.2016.1168808"},{"key":"BFsrep41166_CR38","doi-asserted-by":"publisher","first-page":"e002183","DOI":"10.1161\/JAHA.115.002183","volume":"4","author":"R Lambert","year":"2015","unstructured":"Lambert, R. et al. Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+ -Glucose Cotransport. J Am Heart Assoc 4, e002183 (2015).","journal-title":"J Am Heart Assoc"},{"key":"BFsrep41166_CR39","doi-asserted-by":"publisher","first-page":"e0151585","DOI":"10.1371\/journal.pone.0151585","volume":"11","author":"M Wakisaka","year":"2016","unstructured":"Wakisaka, M., Nagao, T. & Yoshinari, M. Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells. PLoS One 11, e0151585 (2016).","journal-title":"PLoS One"},{"key":"BFsrep41166_CR40","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/hh1101.091265","volume":"88","author":"M Wakisaka","year":"2001","unstructured":"Wakisaka, M. et al. Sodium-coupled glucose transporter as a functional glucose sensor of retinal microvascular circulation. Circ Res 88, 1183\u20131188 (2001).","journal-title":"Circ Res"},{"key":"BFsrep41166_CR41","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s00125-012-2585-2","volume":"55","author":"HE Parker","year":"2012","unstructured":"Parker, H. E. et al. Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion. Diabetologia 55, 2445\u20132455 (2012).","journal-title":"Diabetologia"},{"key":"BFsrep41166_CR42","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1111\/ejn.12354","volume":"38","author":"F Delaere","year":"2013","unstructured":"Delaere, F., Akaoka, H., De Vadder, F., Duchampt, A. & Mithieux, G. Portal glucose influences the sensory, cortical and reward systems in rats. Eur J Neurosci 38, 3476\u20133486 (2013).","journal-title":"Eur J Neurosci"},{"key":"BFsrep41166_CR43","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2337\/db08-0617","volume":"58","author":"E Shen","year":"2009","unstructured":"Shen, E. et al. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 58, 2386\u20132395, doi: 10.2337\/db08-0617 (2009).","journal-title":"Diabetes"},{"key":"BFsrep41166_CR44","doi-asserted-by":"publisher","first-page":"H1693","DOI":"10.1152\/ajpheart.00854.2012","volume":"305","author":"H Taegtmeyer","year":"2013","unstructured":"Taegtmeyer, H., Beauloye, C., Harmancey, R. & Hue, L. Insulin resistance protects the heart from fuel overload in dysregulated metabolic states. American journal of physiology. Heart and circulatory physiology 305, H1693\u20131697 (2013).","journal-title":"American journal of physiology. Heart and circulatory physiology"},{"key":"BFsrep41166_CR45","doi-asserted-by":"publisher","first-page":"18297","DOI":"10.1074\/jbc.M213176200","volume":"278","author":"GT Berry","year":"2003","unstructured":"Berry, G. T. et al. Loss of murine Na+\/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J Biol Chem 278, 18297\u201318302, doi: 10.1074\/jbc.M213176200 (2003).","journal-title":"J Biol Chem"},{"key":"BFsrep41166_CR46","doi-asserted-by":"publisher","first-page":"H239","DOI":"10.1152\/ajpheart.01269.2005","volume":"291","author":"L Bertrand","year":"2006","unstructured":"Bertrand, L. et al. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol 291, H239\u2013250 (2006).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep41166_CR47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/bj20030454","volume":"373","author":"L Wang","year":"2003","unstructured":"Wang, L., Rolfe, M. & Proud, C. G. Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes. Biochem J 373, 603\u2013611 (2003).","journal-title":"Biochem J"},{"key":"BFsrep41166_CR48","first-page":"603","volume":"174","author":"F Bontemps","year":"1978","unstructured":"Bontemps, F., Hue, L. & Hers, H. G. Phosphorylation of glucose in isolated rat hepatocytes. Sigmoidal kinetics explained by the activity of glucokinase alone. Biochem J 174, 603\u2013611 (1978).","journal-title":"Sigmoidal kinetics explained by the activity of glucokinase alone. Biochem J"},{"key":"BFsrep41166_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2014.04.018","volume":"74","author":"G Noppe","year":"2014","unstructured":"Noppe, G. et al. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKalpha1. J Mol Cell Cardiol 74, 32\u201343 (2014).","journal-title":"J Mol Cell Cardiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep41166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T16:31:26Z","timestamp":1671813086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep41166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,13]]}},"alternative-id":["BFsrep41166"],"URL":"https:\/\/doi.org\/10.1038\/srep41166","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]},"assertion":[{"value":"21 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41166"}}